{"pmid":32406778,"title":"Ultra-shortwave diathermy - a new purported treatment for management of patients with COVID-19.","text":["Ultra-shortwave diathermy - a new purported treatment for management of patients with COVID-19.","The pandemic spread of coronavirus disease 2019 (COVID-19) has driven efforts to address the global threat to public health and there is increasing pressure to exploit interventions to manage the pneumonic inflammation manifested in this disease. Ultra-shortwave diathermy (USWD) is proposed by some rehabilitation professions in China, purportedly to minimise pneumonic inflammation. However, treatment of any symptomatic pneumonia should be evidence-based. There is no valid evidence, published in English, which establishes any benefit of USWD in pulmonary conditions, let alone COVID-19. The need for rigorous research and evidence-based practice is discussed in this article. Novel interventions require a solid physiological basis and must undergo rigorous testing prior to clinical adoption even during a pandemic. We are of the view that deployment of USWD in patients with COVID-19 must be prudent and supported by a logical scientific basis.","Physiother Theory Pract","Yu, Homer Peng-Ming","Jones, Alice Ym","Dean, E","Liisa Laakso, E-","32406778"],"abstract":["The pandemic spread of coronavirus disease 2019 (COVID-19) has driven efforts to address the global threat to public health and there is increasing pressure to exploit interventions to manage the pneumonic inflammation manifested in this disease. Ultra-shortwave diathermy (USWD) is proposed by some rehabilitation professions in China, purportedly to minimise pneumonic inflammation. However, treatment of any symptomatic pneumonia should be evidence-based. There is no valid evidence, published in English, which establishes any benefit of USWD in pulmonary conditions, let alone COVID-19. The need for rigorous research and evidence-based practice is discussed in this article. Novel interventions require a solid physiological basis and must undergo rigorous testing prior to clinical adoption even during a pandemic. We are of the view that deployment of USWD in patients with COVID-19 must be prudent and supported by a logical scientific basis."],"journal":"Physiother Theory Pract","authors":["Yu, Homer Peng-Ming","Jones, Alice Ym","Dean, E","Liisa Laakso, E-"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32406778","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1080/09593985.2020.1757264","keywords":["ultra-shortwave diathermy; covid-19; evidence-based practice"],"locations":["Ultra","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1666802845283778560,"score":9.490897,"similar":[{"pmid":32425415,"pmcid":"PMC7229731","title":"It is time for a more cautious approach to surgical diathermy, especially in COVID-19 outbreak: A schematic review.","text":["It is time for a more cautious approach to surgical diathermy, especially in COVID-19 outbreak: A schematic review.","Background: Many surgeons are unaware of the risks posed by the surgical diathermy. Apart from the numerous chemicals, surgical smoke had been shown to harbour intact bacterial and virus particles especially COVID-19 in the current time. Objective: To identify the inhalational, infectious, chemical, and mutagenic risks of surgical smoke and suggest evidence-based hazard reduction strategies. Also to cogitate on the very high risk of viral spread spread by the use of surgical diathermy in COVID-19 outbreak. Methods: A review of articles indexed for MEDLINE on PubMed using the keywords surgical smoke, diathermy, electrocautery, surgical smoke hazards, smoke evacuator, and guidelines for surgical smoke safety was performed. The review included evidences from 50 articles from the dermatology, surgery, infectious disease, obstetrics, and cancer biology literature. Results: There are risks associated with surgical smoke. Although some surgeons were aware, majority were not keen in the hazard reduction strategies. Conclusion: Many chemical and biological particles have been found in surgical smoke. It is highly recommended to follow the standardised guidelines for surgical smoke safety. Surgical smoke carries full virus particle(such as COVID-19 virus), it is strongly recommended to minimise or avoid electrocautery during the COVID-19 outbreak.","J Orthop","Karuppal, Raju","Surendran, Sibin","Patinharayil, Gopinathan","Muhammed Fazil, V V","Marthya, Anwar","32425415"],"abstract":["Background: Many surgeons are unaware of the risks posed by the surgical diathermy. Apart from the numerous chemicals, surgical smoke had been shown to harbour intact bacterial and virus particles especially COVID-19 in the current time. Objective: To identify the inhalational, infectious, chemical, and mutagenic risks of surgical smoke and suggest evidence-based hazard reduction strategies. Also to cogitate on the very high risk of viral spread spread by the use of surgical diathermy in COVID-19 outbreak. Methods: A review of articles indexed for MEDLINE on PubMed using the keywords surgical smoke, diathermy, electrocautery, surgical smoke hazards, smoke evacuator, and guidelines for surgical smoke safety was performed. The review included evidences from 50 articles from the dermatology, surgery, infectious disease, obstetrics, and cancer biology literature. Results: There are risks associated with surgical smoke. Although some surgeons were aware, majority were not keen in the hazard reduction strategies. Conclusion: Many chemical and biological particles have been found in surgical smoke. It is highly recommended to follow the standardised guidelines for surgical smoke safety. Surgical smoke carries full virus particle(such as COVID-19 virus), it is strongly recommended to minimise or avoid electrocautery during the COVID-19 outbreak."],"journal":"J Orthop","authors":["Karuppal, Raju","Surendran, Sibin","Patinharayil, Gopinathan","Muhammed Fazil, V V","Marthya, Anwar"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425415","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jor.2020.05.013","keywords":["covid-19 outbreak","electrocautery","operating room hazards","surgical diathermy","surgical plume","surgical smoke"],"topics":["Prevention"],"weight":1,"_version_":1667252837811224576,"score":133.08914},{"pmid":32227493,"title":"Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19.","text":["Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19.","Confronting the challenge of the outbreak of COVID-19 should sharpen our focus on global drug access as a key issue in antiviral therapy testing. The testing and adoption of effective therapies for novel coronaviruses are hampered by the challenge of conducting controlled studies during a state of emergency. The access to direct antiviral drugs, such as ribavirin, that have an existing inventory and reliable supply chain may be a priority consideration for therapies developed for the 2019-nCoV infection outbreaks and any strain variants that may emerge. On the basis of the direct antiviral activity of ribavirin against 2019-nCoV in vitro and evidence for potency enhancement strategies developed during the prior SARS and MERS outbreaks, ribavirin may significantly impact our ability to end the lingering outbreaks in China and slow outbreaks in other countries. The apparent COVID-19 pandemic provides an opportunity to follow dosage guidelines for treatment with ribavirin, test new therapeutic concepts, and conduct controlled testing to apply the scientific rigor required to address the controversy around this mainstay of antiviral therapy.","J Med Virol","Khalili, Jahan S","Zhu, Hai","Mak, Nga Sze Amanda","Yan, Yongqi","Zhu, Yi","32227493"],"abstract":["Confronting the challenge of the outbreak of COVID-19 should sharpen our focus on global drug access as a key issue in antiviral therapy testing. The testing and adoption of effective therapies for novel coronaviruses are hampered by the challenge of conducting controlled studies during a state of emergency. The access to direct antiviral drugs, such as ribavirin, that have an existing inventory and reliable supply chain may be a priority consideration for therapies developed for the 2019-nCoV infection outbreaks and any strain variants that may emerge. On the basis of the direct antiviral activity of ribavirin against 2019-nCoV in vitro and evidence for potency enhancement strategies developed during the prior SARS and MERS outbreaks, ribavirin may significantly impact our ability to end the lingering outbreaks in China and slow outbreaks in other countries. The apparent COVID-19 pandemic provides an opportunity to follow dosage guidelines for treatment with ribavirin, test new therapeutic concepts, and conduct controlled testing to apply the scientific rigor required to address the controversy around this mainstay of antiviral therapy."],"journal":"J Med Virol","authors":["Khalili, Jahan S","Zhu, Hai","Mak, Nga Sze Amanda","Yan, Yongqi","Zhu, Yi"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32227493","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25798","keywords":["covid-19","novel coronavirus","ribavirin"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Ribavirin"],"topics":["Treatment"],"weight":1,"_version_":1666138492431761410,"score":120.70041},{"pmid":32285293,"pmcid":"PMC7152693","title":"Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV.","text":["Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV.","Since December 2019, the infection of the new coronavirus (COVID-19) caused an outbreak of new coronavirus pneumonia in Wuhan, China, and caused great public concern. Both COVID-19 and SARS-CoV belong to the coronavirus family and both invade target cells through ACE2. An in-depth understanding of ACE2 and a series of physiological and physiological changes caused by the virus invading the human body may help to discover and explain the corresponding clinical phenomena and then deal with them timely. In addition, ACE2 is a potential therapeutic target. This article will summarize the role of ACE2 in multiple organ damage caused by COVID-19 and SARS-CoV, targeted blocking drugs against ACE2, and drugs that inhibit inflammation in order to provide the basis for subsequent related research, diagnosis and treatment, and drug development.","Eur J Clin Microbiol Infect Dis","Li, Shu-Ren","Tang, Zi-Jian","Li, Zai-Han","Liu, Xuan","32285293"],"abstract":["Since December 2019, the infection of the new coronavirus (COVID-19) caused an outbreak of new coronavirus pneumonia in Wuhan, China, and caused great public concern. Both COVID-19 and SARS-CoV belong to the coronavirus family and both invade target cells through ACE2. An in-depth understanding of ACE2 and a series of physiological and physiological changes caused by the virus invading the human body may help to discover and explain the corresponding clinical phenomena and then deal with them timely. In addition, ACE2 is a potential therapeutic target. This article will summarize the role of ACE2 in multiple organ damage caused by COVID-19 and SARS-CoV, targeted blocking drugs against ACE2, and drugs that inhibit inflammation in order to provide the basis for subsequent related research, diagnosis and treatment, and drug development."],"journal":"Eur J Clin Microbiol Infect Dis","authors":["Li, Shu-Ren","Tang, Zi-Jian","Li, Zai-Han","Liu, Xuan"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32285293","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s10096-020-03883-y","keywords":["angiotensin-converting enzyme 2 (ace2)","new coronavirus (covid-19)","sars coronavirus (sars-cov)"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138491289862144,"score":100.96607},{"pmid":32294814,"title":"[Recommendations for respiratory rehabilitation of coronavirus disease 2019 in adult].","text":["[Recommendations for respiratory rehabilitation of coronavirus disease 2019 in adult].","COVID-19 is a highly infectious respiratory infection disease, which leads to dysfunction of respiratory, physical, and psychological of the patients. pulmonary rehabilitation is an important intervention for clinical patients as well as cure patients. With the deeper cognition of COVID-19 and accumulation of clinical experience, we proposed the recommendations for pulmonary rehabilitation of COVID-19 in adults based on the opinions of front-line clinical experts involved in the management of this epidemic and a review of the relevant literature and evidences: (1)for the inpatients with COVID-19, pulmonary rehabilitation would relieve the symptoms of dyspnea, anxiety, and depression; eventually improve physical function and the quality of life; (2)For severe/critical inpatients, the early performance of pulmonary rehabilitation is not suggested. (3)For isolating patients, the pulmonary rehabilitation guidence should be conducted through education video, instruction manual or remote consultation. (4)Assessment and monitor should be performed throughout the entire pulmonary rehabilitation process.(5)Taking proper grading protection following the guideline. These recommendations can serve as a clinical practice guidence and basis for pulmonary rehabilitation of COVID-19.","Zhonghua Jie He He Hu Xi Za Zhi","32294814"],"abstract":["COVID-19 is a highly infectious respiratory infection disease, which leads to dysfunction of respiratory, physical, and psychological of the patients. pulmonary rehabilitation is an important intervention for clinical patients as well as cure patients. With the deeper cognition of COVID-19 and accumulation of clinical experience, we proposed the recommendations for pulmonary rehabilitation of COVID-19 in adults based on the opinions of front-line clinical experts involved in the management of this epidemic and a review of the relevant literature and evidences: (1)for the inpatients with COVID-19, pulmonary rehabilitation would relieve the symptoms of dyspnea, anxiety, and depression; eventually improve physical function and the quality of life; (2)For severe/critical inpatients, the early performance of pulmonary rehabilitation is not suggested. (3)For isolating patients, the pulmonary rehabilitation guidence should be conducted through education video, instruction manual or remote consultation. (4)Assessment and monitor should be performed throughout the entire pulmonary rehabilitation process.(5)Taking proper grading protection following the guideline. These recommendations can serve as a clinical practice guidence and basis for pulmonary rehabilitation of COVID-19."],"journal":"Zhonghua Jie He He Hu Xi Za Zhi","date":"2020-04-17T11:00:00Z","year":2020,"_id":"32294814","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.3760/cma.j.cn112147-20200228-00206","keywords":["covid-19","pulmonary rehabilitation","recommendations"],"topics":["Prevention"],"weight":1,"_version_":1666138493213999106,"score":97.671036},{"pmid":32316718,"title":"Systematic rapid \"living\" review on rehabilitation needs due to covid-19: update to march 31st 2020.","text":["Systematic rapid \"living\" review on rehabilitation needs due to covid-19: update to march 31st 2020.","BACKGROUND: The outbreak of Covid-19 epidemics has challenged the provision of health care worldwide, highlighting the main flaws of some national health systems with respect to their capacity to cope with the needs of frail subjects. People experiencing disability due to Covid-19 express specific rehabilitation needs that deserve a systematic evidence-based approach. OBJECTIVES: To provide the rehabilitation community with updates on the latest scientific literature on rehabilitation needs due to Covid-19. The first rapid \"living\" review will present the results of a systematic search performed up to March 31st, 2020. METHODS: A systematic search on PubMed, Pedro and Google Scholar was performed using the search terms: \"Covid-19\", \"Coronavirus\", \"severe acute respiratory syndrome coronavirus 2\", \"rehabilitation\", \"physical therapy modalities\", \"exercise\", \"occupational therapy\", and \"late complications\". Papers published up to March 31st, 2020, in English, were included. RESULTS: Out of the 2758 articles retrieved, 9 were included in the present review. Four of them are \"calls for action\", 3 provide recommendations about rehabilitation interventions in the acute phase, 2 address the needs of people quarantined at home or with restricted mobility due to the lockdown, and 1 provides a Core Outcome Set to be used in clinical trials to test the efficacy of health strategies in managing Covid-19 patients. CONCLUSIONS: All selected papers were based on previous literature and not on the current Covid-19 pandemic. Main messages included: 1) early rehabilitation should be granted to inpatients with Covid-19; 2) people with restricted mobility due to quarantine or lockdown should receive exercise programs to reduce the risk of frailty, sarcopenia, cognitive decline and depression; 3) telerehabilitation may represent the first option for people at home. Further updates are warranted in order to characterize the emerging disability in Covid-19 survivors and the adverse effects on the health of chronically disabled people.","Eur J Phys Rehabil Med","Ceravolo, Maria G","De Sire, Alessandro","Andrenelli, Elisa","Negrini, Francesco","Negrini, Stefano","32316718"],"abstract":["BACKGROUND: The outbreak of Covid-19 epidemics has challenged the provision of health care worldwide, highlighting the main flaws of some national health systems with respect to their capacity to cope with the needs of frail subjects. People experiencing disability due to Covid-19 express specific rehabilitation needs that deserve a systematic evidence-based approach. OBJECTIVES: To provide the rehabilitation community with updates on the latest scientific literature on rehabilitation needs due to Covid-19. The first rapid \"living\" review will present the results of a systematic search performed up to March 31st, 2020. METHODS: A systematic search on PubMed, Pedro and Google Scholar was performed using the search terms: \"Covid-19\", \"Coronavirus\", \"severe acute respiratory syndrome coronavirus 2\", \"rehabilitation\", \"physical therapy modalities\", \"exercise\", \"occupational therapy\", and \"late complications\". Papers published up to March 31st, 2020, in English, were included. RESULTS: Out of the 2758 articles retrieved, 9 were included in the present review. Four of them are \"calls for action\", 3 provide recommendations about rehabilitation interventions in the acute phase, 2 address the needs of people quarantined at home or with restricted mobility due to the lockdown, and 1 provides a Core Outcome Set to be used in clinical trials to test the efficacy of health strategies in managing Covid-19 patients. CONCLUSIONS: All selected papers were based on previous literature and not on the current Covid-19 pandemic. Main messages included: 1) early rehabilitation should be granted to inpatients with Covid-19; 2) people with restricted mobility due to quarantine or lockdown should receive exercise programs to reduce the risk of frailty, sarcopenia, cognitive decline and depression; 3) telerehabilitation may represent the first option for people at home. Further updates are warranted in order to characterize the emerging disability in Covid-19 survivors and the adverse effects on the health of chronically disabled people."],"journal":"Eur J Phys Rehabil Med","authors":["Ceravolo, Maria G","De Sire, Alessandro","Andrenelli, Elisa","Negrini, Francesco","Negrini, Stefano"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32316718","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.23736/S1973-9087.20.06329-7","locations":["sarcopenia"],"topics":["Prevention","Treatment"],"weight":1,"_version_":1666138493702635520,"score":97.26725}]}